Digestive & Intestinal Remedies (Pharmacies) - Cuba

  • Cuba
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$10.57m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.26%, resulting in a market volume of US$10.68m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.95 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Cuba is experiencing significant growth due to several key factors.

Customer preferences:
Cuban customers are increasingly seeking digestive and intestinal remedies to address common health issues such as indigestion, heartburn, and stomach ulcers. This growing demand is driven by a combination of factors, including changing dietary habits, increased stress levels, and a higher prevalence of gastrointestinal disorders. Customers are looking for effective and affordable remedies that can provide relief from these ailments.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Cuba is the rising popularity of natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternatives to conventional pharmaceutical products. This trend is driven by a growing awareness of the potential side effects of certain medications and a desire for more holistic approaches to healthcare. As a result, there has been an increase in the availability and sales of natural and herbal remedies for digestive and intestinal issues in Cuban pharmacies. Another trend in the market is the increasing availability of over-the-counter (OTC) medications for digestive and intestinal issues. Previously, many of these medications were only available by prescription, but there has been a shift towards making them more accessible to customers without the need for a doctor's visit. This has led to an increase in self-medication and a greater reliance on OTC remedies for common digestive ailments.

Local special circumstances:
Cuba's healthcare system plays a significant role in shaping the Digestive & Intestinal Remedies market. The country has a well-developed primary healthcare system, with a network of local clinics and pharmacies that provide accessible and affordable healthcare services to the population. This infrastructure supports the distribution and availability of digestive and intestinal remedies throughout the country. Additionally, Cuba has a strong tradition of herbal medicine and natural remedies. This cultural preference for natural treatments has influenced customer preferences and the availability of natural and herbal digestive and intestinal remedies in the market.

Underlying macroeconomic factors:
Cuba's growing tourism industry is a key macroeconomic factor driving the growth of the Digestive & Intestinal Remedies market. As more tourists visit the country, there is an increased demand for healthcare products and services, including digestive and intestinal remedies. This influx of tourists has created a new customer base and has contributed to the overall growth of the market. Furthermore, Cuba's economic reforms and opening up to foreign investment have led to increased consumer spending power and a growing middle class. This has resulted in higher disposable incomes and a greater willingness to spend on healthcare products, including digestive and intestinal remedies. In conclusion, the Digestive & Intestinal Remedies market in Cuba is experiencing growth due to changing customer preferences, including a preference for natural and herbal remedies, and an increasing availability of OTC medications. The country's healthcare system, cultural preferences, and macroeconomic factors such as tourism and economic reforms also contribute to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)